MeiraGTx, LLC
Clinical trials sponsored by MeiraGTx, LLC, explained in plain language.
A gene therapy company, subsidiary of MeiraGTx Holdings.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a single gene therapy dose restore saliva flow years after radiation? Results expected Mar 2027 (estimated)
- Gene therapy could restore saliva flow in dry mouth sufferers Results expected Jun 2027 (estimated)
-
Can a single gene therapy calm Parkinson's for years?
Disease control OngoingThis study follows people with Parkinson's disease who previously received AAV-GAD, a gene therapy infused into a brain region that helps control movement. The goal is to check how safe the treatment remains over many years, watching for any drug-related side effects. Researchers…
Phase 1/2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Gene therapy could restore saliva flow in dry mouth sufferers
Disease control OngoingThis study tests a gene therapy (AAV2-hAQP1) injected into the saliva glands to see if it can safely increase saliva production in people with long-term dry mouth after radiation for head and neck cancer. About 276 adults who completed radiation at least 3 years ago will receive …
Phase 2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Gene therapy for radiation dry mouth tracked long-term
Disease control By invitation onlyThis study follows adults who previously received a gene therapy (AAV2-hAQP1) for dry mouth caused by radiation treatment for head and neck cancers. Researchers will check for side effects and how well the therapy works over time. About 276 people who already got the therapy in a…
Phase 2 • Sponsor: MeiraGTx, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can a single gene therapy dose restore saliva flow years after radiation?
Symptom relief OngoingThis study follows people who received an experimental gene therapy, AAV2hAQP1, for chronic dry mouth caused by past radiation treatment for cancer. Researchers are checking whether the therapy remains safe and whether any improvement in saliva production lasts over time. The goa…
Sponsor: MeiraGTx, LLC • Aim: Symptom relief
Last updated Jul 24, 2026 00:00 UTC